4//SEC Filing
SARIN ARADHANA 4
Accession 0000899866-21-000076
CIK 0000899866other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:52 PM ET
Size
5.1 KB
Accession
0000899866-21-000076
Insider Transaction Report
Form 4
SARIN ARADHANA
Chief Strategy & Business Off
Transactions
- Disposition to Issuer
Common Stock, par value $.0001 per share
2021-07-21−120,253→ 0 total
Footnotes (1)
- [F1]Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC. In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the "Merger Consideration").
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001729110
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:52 PM ET
- Size
- 5.1 KB